136
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association Between High-Sensitivity C-Reactive Protein and Prognosis of Patients with Acute Cerebral Infarction

ORCID Icon, , , &
Pages 1771-1778 | Received 07 Jun 2022, Accepted 17 Aug 2022, Published online: 20 Aug 2022

References

  • Feigin VL, Stark BA, Johnson CO, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820. doi:10.1016/s1474-4422(21)00252-0
  • Lin Y, Wang K, Ji D, Gong Z, Wang Z. Correlation between plasma high mobility group protein N1 level and the prognosis of patients with acute cerebral infarction: preliminary findings. Neuropsychiatr Dis Treat. 2022;18:907–913. doi:10.2147/ndt.S359879
  • Gao HH, Gao LB, Wen JM. Correlations of MCP-1 −2518A>G polymorphism and serum levels with cerebral infarction risk: a meta-analysis. DNA Cell Biol. 2014;33(8):522–530. doi:10.1089/dna.2013.2263
  • Fu X, Liu Q, Zeng X, Huang S, Huang R, Gao Q. Association between cerebral arterial stiffness and large artery atherosclerosis in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2018;27(11):2993–3000. doi:10.1016/j.jstrokecerebrovasdis.2018.06.033
  • Li S, Song X, Hu Q, et al. Association of plaque features with infarct patterns in patients with acutely symptomatic middle cerebral artery atherosclerotic disease. J Stroke Cerebrovasc Dis. 2021;30(5):105724. doi:10.1016/j.jstrokecerebrovasdis.2021.105724
  • Ridker PM, Silvertown JD. Inflammation, C-reactive protein, and atherothrombosis. J Periodontol. 2008;79(8 Suppl):1544–1551. doi:10.1902/jop.2008.080249
  • Ponsaerts L, Alders L, Schepers M, et al. Neuroinflammation in ischemic stroke: inhibition of cAMP-specific Phosphodiesterases (PDEs) to the rescue. Biomedicines. 2021;9(7). doi:10.3390/biomedicines9070703
  • Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17(7):796–808. doi:10.1038/nm.2399
  • Zhang X, Huang WJ, Yu ZG. Relationship between the hypersensitive c-reactive protein (hs-CRP) level and the prognosis of acute brainstem infarction. Cell Biochem Biophys. 2015;72(1):107–110. doi:10.1007/s12013-014-0414-6
  • Cai Z, He W, Zhuang FJ, Chen Y. The role of high high-sensitivity C-reactive protein levels at admission on poor prognosis after acute ischemic stroke. Int J Neurosci. 2019;129(5):423–429. doi:10.1080/00207454.2018.1538139
  • Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41. doi:10.1161/01.str.24.1.35
  • Zhang XG, Xue J, Yang WH, et al. Inflammatory markers as independent predictors for stroke outcomes. Brain Behav. 2021;11(1):e01922. doi:10.1002/brb3.1922
  • Iadecola C, Buckwalter MS, Anrather J. Immune responses to stroke: mechanisms, modulation, and therapeutic potential. J Clin Invest. 2020;130(6):2777–2788. doi:10.1172/jci135530
  • Anrather J, Iadecola C. Inflammation and Stroke: an Overview. Neurotherapeutics. 2016;13(4):661–670. doi:10.1007/s13311-016-0483-x
  • De Meyer SF, Denorme F, Langhauser F, Geuss E, Fluri F, Kleinschnitz C. Thromboinflammation in stroke brain damage. Stroke. 2016;47(4):1165–1172. doi:10.1161/strokeaha.115.011238
  • Maida CD, Norrito RL, Daidone M, Tuttolomondo A, Pinto A. Neuroinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches. Int J Mol Sci. 2020;21(18). doi:10.3390/ijms21186454
  • Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):142. doi:10.1186/s12974-019-1516-2
  • Park SW, Park SS, Kim EJ, Sung WS, Ha IH, Jung B. Sex differences in the association between self-rated health and high-sensitivity C-reactive protein levels in Koreans: a cross-sectional study using data from the Korea National Health and Nutrition Examination Survey. Health Qual Life Outcomes. 2020;18(1):341. doi:10.1186/s12955-020-01597-5
  • Makita S, Nakamura M, Satoh K, et al. Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population. Atherosclerosis. 2009;204(1):234–238. doi:10.1016/j.atherosclerosis.2008.07.040
  • Zhou Y, Han W, Gong D, Man C, Fan Y. Hs-CRP in stroke: a meta-analysis. Clin Chim Acta. 2016;453:21–27. doi:10.1016/j.cca.2015.11.027
  • Bustamante A, Simats A, Vilar-Bergua A, García-Berrocoso T, Montaner J. Blood/brain biomarkers of inflammation after stroke and their association with outcome: from C-reactive protein to damage-associated molecular patterns. Neurotherapeutics. 2016;13(4):671–684. doi:10.1007/s13311-016-0470-2
  • Zhang XL, Dong YT, Liu Y, Zhang Y, Li TT, Hu FY. Effects of dl-3-n-butylphthalide on serum lipoprotein-associated phospholipase A2 and hypersensitive C-reactive protein levels in acute cerebral infarction. Brain Behav. 2019;9(12):e01469. doi:10.1002/brb3.1469
  • Tohgi H, Konno S, Takahashi S, Koizumi D, Kondo R, Takahashi H. Activated coagulation/fibrinolysis system and platelet function in acute thrombotic stroke patients with increased C-reactive protein levels. Thromb Res. 2000;100(5):373–379. doi:10.1016/s0049-3848(00)00356-x
  • Lv P, Jin H, Liu Y, et al. Comparison of risk factor between lacunar stroke and large artery atherosclerosis stroke: a cross-sectional study in China. PLoS One. 2016;11(3):e0149605. doi:10.1371/journal.pone.0149605
  • Knight-Greenfield A, Nario JJQ, Gupta A. Causes of acute stroke: a patterned approach. Radiol Clin North Am. 2019;57(6):1093–1108. doi:10.1016/j.rcl.2019.07.007